BioAtla Statistics

Total Valuation

BioAtla has a market cap or net worth of $67.68 million. The enterprise value is $16.29 million.

Market Cap	67.68M
Enterprise Value	16.29M

Important Dates

The last earnings date was Thursday, November 7, 2024, after market close.

Earnings Date	Nov 7, 2024
Ex-Dividend Date	n/a

Share Statistics

BioAtla has 48.35 million shares outstanding. The number of shares has increased by 3.25% in one year.

Current Share Class	48.35M
Shares Outstanding	48.35M
Shares Change (YoY)	+3.25%
Shares Change (QoQ)	+0.25%
Owned by Insiders (%)	9.00%
Owned by Institutions (%)	27.02%
Float	34.82M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	6.48
Forward PS	n/a
PB Ratio	3.12
P/TBV Ratio	2.88
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	1.48
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 3.11, with a Debt / Equity ratio of 0.05.

Current Ratio	3.11
Quick Ratio	2.90
Debt / Equity	0.05
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	n/a

Financial Efficiency

Return on equity (ROE) is -139.06% and return on invested capital (ROIC) is -88.52%.

Return on Equity (ROE)	-139.06%
Return on Assets (ROA)	-50.47%
Return on Capital (ROIC)	-88.52%
Revenue Per Employee	$169,231
Profits Per Employee	-$1.26M
Employee Count	65
Asset Turnover	0.10
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -12.87% in the last 52 weeks. The beta is 1.02, so BioAtla's price volatility has been similar to the market average.

Beta (5Y)	1.02
52-Week Price Change	-12.87%
50-Day Moving Average	1.89
200-Day Moving Average	2.12
Relative Strength Index (RSI)	34.47
Average Volume (20 Days)	1,097,729

Short Selling Information

The latest short interest is 4.87 million, so 10.07% of the outstanding shares have been sold short.

Short Interest	4.87M
Short Previous Month	5.24M
Short % of Shares Out	10.07%
Short % of Float	13.98%
Short Ratio (days to cover)	2.76

Income Statement

In the last 12 months, BioAtla had revenue of $11.00 million and -$81.82 million in losses. Loss per share was -$1.70.

Revenue	11.00M
Gross Profit	-63.12M
Operating Income	-86.24M
Pretax Income	-104.56M
Net Income	-81.82M
EBITDA	-85.17M
EBIT	-86.24M
Loss Per Share	-$1.70

Full Income Statement

Balance Sheet

The company has $56.52 million in cash and $1.25 million in debt, giving a net cash position of $55.27 million or $1.14 per share.

Cash & Cash Equivalents	56.52M
Total Debt	1.25M
Net Cash	55.27M
Net Cash Per Share	$1.14
Equity (Book Value)	22.97M
Book Value Per Share	0.48
Working Capital	41.11M

Full Balance Sheet

Cash Flow

In the last 12 months, operating cash flow was -$85.08 million and capital expenditures -$8,000, giving a free cash flow of -$85.08 million.

Operating Cash Flow	-85.08M
Capital Expenditures	-8,000
Free Cash Flow	-85.08M
FCF Per Share	-$1.76

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-783.95%
Pretax Margin	-743.79%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

BioAtla does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-3.25%
Shareholder Yield	-3.25%
Earnings Yield	-123.54%
FCF Yield	-128.47%

Analyst Forecast

The average price target for BioAtla is $5.00, which is 257.14% higher than the current price. The consensus rating is "Buy".

Price Target	$5.00
Price Target Difference	257.14%
Analyst Consensus	Buy
Analyst Count	2
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	-32.50%

Stock Forecasts

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

BioAtla has an Altman Z-Score of -12.69. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-12.69
Piotroski F-Score	n/a